National

Blossom Pharma obtains GMP license from Infarmed to manufacture medicinal cannabis

Published

2 years ago

October

Blossom Pharma received GMP I and GMP II licenses from Infarmed – National Authority for Medicines and Health Products, IP to manufacture medicinal cannabis. The accreditation represents a fundamental achievement for Blossom, as it allows it to begin large-scale production of medicinal cannabis to satisfy the growing demand for cannabinoid-based treatments.

GMP I and II licenses represent the highest standards in pharmaceutical production, ensuring that products are safe and consistently controlled. In a press release, the company states that “this certification emphasizes Blossom Pharma's commitment to quality, safety, effectiveness and compliance, as it undergoes rigorous evaluations to validate the effectiveness of its manufacturing processes, operational procedures and safety measures. quality control".

On the other hand, Blossom continues to prioritize medical cannabis research and development, focusing on creating cost-effective production methods for a variety of products to treat various medical pathologies. GMP I and II licenses allow the company to improve its production capabilities, expand its product portfolio and solidify its presence in the international medical cannabis market.

Speaking to Cannareporter, Oskar Fletcher, CEO of Blossom, said that Infarmed's GMP I and II licenses were received with “immense pride and enthusiasm”, as they represent “a monumental achievement for Blossom, underlining our tireless pursuit of excellence in manufacturing medical cannabis products. This certification not only validates our unwavering commitment to quality, but also facilitates our mission to provide patients around the world with access to innovative solutions.”

A Blossom Pharma is a company originally from the United Kingdom, which began operations in Portugal in 2021 and is headquartered in Benavente, in the district of Santarém. With a few more companies receiving Infarmed licenses in recent months, Cannareporter is now updating the map of licensed companies in Portugal and will publish it soon.

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Laura Ramos

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 2018st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “What does Lisbon say?” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura made the documentary “Pacientes” in XNUMX and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.